会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • METHODS OF TREATING MICROBIAL INFECTIONS
    • 治疗微生物感染的方法
    • WO1996040117A1
    • 1996-12-19
    • PCT/US1996008972
    • 1996-06-03
    • THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLGEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.DUKE UNIVERSITYAUBURN UNIVERSITYTIDWELL, Richard, R.HALL, James, E.BOYKIN, David, W.DYKSTRA, Christine, C.PERFECT, John, R.BLAGBURN, Byron, L.
    • THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILLGEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.DUKE UNIVERSITYAUBURN UNIVERSITY
    • A61K31/40
    • C07D403/04A61K31/403A61K31/4178A61K31/4184A61K31/506C07D209/86C07D209/88C07D403/14Y02A50/488
    • The present invention provides methods for treating Cryptococcus neoformans, Cryptosporidium parvum, and Candida albicans in a subject in need of such treatment. The methods comprise administering to the subject a compound of Formula (I), wherein X is located in the para or meta positions and is loweralkyl, loweralkoxy, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, alkylaryl, halogen, or (a), wherein each R2 is independently selected from the group consisting of H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl or two R2 groups together represent C2-C10 alkylene, or two R2 groups together represent (b), wherein m is from 1-3 and R4 is H, (c) or -CONHR5NR6R7, wherein R5 is loweralkyl, R6 and R7 are each independently selected from the group consisting of H and lower alkyl; each R8 is independently selected from the group consisting of H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl, or two R8 groups together represent C2-C10 alkylene; R9 is H, hydroxy, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl; R3 is H, hydroxy, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, or alkylaryl; R1 is H, loweralkyl, alkoxyalkyl, hydroxyalkyl, aminoalkyl, alkylaminoalkyl, cycloalkyl, aryl, alkylaryl, or halogen; or a pharmaceutically acceptable salt thereof.
    • 本发明提供了在需要这种治疗的受试者中治疗隐球菌新隐球蛋白,小隐孢子虫和白色念珠菌的方法。 所述方法包括向受试者施用式(I)化合物,其中X位于对位或间位,且为低级烷基,低级烷氧基,烷氧基烷基,羟烷基,氨基烷基,烷基氨基烷基,环烷基,芳基,烷基芳基,卤素或( ),其中每个R 2独立地选自H,低级烷基,烷氧基烷基,羟基烷基,氨基烷基,烷基氨基烷基,环烷基,芳基或烷基芳基或两个R 2基团一起表示C 2 -C 10亚烷基,或两个R 2基团一起表示(b ),其中m为1-3,R4为H,(c)或-CONHR5NR6R7,其中R5为低级烷基,R6和R7各自独立地选自H和低级烷基; 每个R 8独立地选自H,低级烷基,烷氧基烷基,羟基烷基,氨基烷基,烷基氨基烷基,环烷基,芳基或烷基芳基,或两个R 8基团一起表示C 2 -C 10亚烷基; R9是H,羟基,低级烷基,烷氧基烷基,羟基烷基,氨基烷基,烷基氨基烷基,环烷基,芳基或烷基芳基; R3是H,羟基,低级烷基,烷氧基烷基,羟基烷基,氨基烷基,烷基氨基烷基,环烷基,芳基或烷基芳基; R1是H,低级烷基,烷氧基烷基,羟基烷基,氨基烷基,烷基氨基烷基,环烷基,芳基,烷基芳基或卤素; 或其药学上可接受的盐。